X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.13
Delayed Data
As of Jun 18
 +0.17 / +8.67%
Today’s Change
1.55
Today|||52-Week Range
4.14
-6.87%
Year-to-Date
Institutional investors purchased a net $6.5 thousand shares of XTLB during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 1.01% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders0.66%
Other institutional0.35%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2018MORGAN STANLEY & CO. LLC  Bought 5.1 Thousand shares of X T L Biopharmaceuticals ...
3/31/2018BANK OF AMERICA, NA (PRIVATE BAN...  Bought 1.0 Thousand shares of X T L Biopharmaceuticals ...
3/31/2018UBS SECURITIES LLC  Bought 426.00 shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Invesco Asset Management Ltd.0.51%25,96148,80700.00%
Morgan Stanley & Co. LLC0.31%15,86129,819+5,100+47.39%
IBI Mutual Funds Management (1978...0.16%8,06015,15300.00%
UBS Securities LLC0.02%1,1292,123+426+60.60%
Bank of America, NA (Private Bank...0.02%1,0001,880+1,000--

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.38%19,60236,852+108+0.55%
I.B.I. Foreign Equity Liable0.16%8,06015,15300.00%
Keystone Investment Trust Plc0.10%5,1689,71600.00%
Invesco Perpetual UK 2 Invt. Seri...0.02%1,1912,23900.00%